CNJ-016 Injection and Insulin Glargine (U-300) Pens
Determining the interaction of CNJ-016 Injection and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: vaccinia immune globulin
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: n.a.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- CNJ-016 Injection-Insulin glargine and lixisenatide
- CNJ-016 Injection-Insulin glargine and lixisenatide Subcutaneous
- CNJ-016 Injection-Insulin glargine, recombinant Subcutaneous
- CNJ-016 Injection-Insulin glulisine
- CNJ-016 Injection-Insulin Glulisine (Cartridges and Pens)
- CNJ-016 Injection-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Co-Gesic
- Insulin Glargine (U-300) Pens-Co-trimoxazole
- Insulin Glargine (U-300) Pens-Co-Veratrol
- Insulin Glargine (U-300) Pens-Coagadex
- Insulin Glargine (U-300) Pens-Coagulation factor IX
- Insulin Glargine (U-300) Pens-Coagulation factor ix recombinant Intravenous